Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT06761703
Eligibility Criteria:
Inclusion Criteria:
* Adults 18 - 80 years of age.
* Living in the United States.
* Consented from the Inspire online platform patient community for COSMOS-DIGITAL.
* Self-Reported current use of, and intention to continue for at least 30 days, one of the following medications for the indications of weight management/obesity:
* Semaglutide (wegovy)
* Tirzepatide (zepbound)
Exclusion Criteria:
* Currently receiving treatment in another investigational device or drug study, or participation in a current clinical trial.
* Self-reported sensitivity/allergy to any of the components of the self-draw collection device including stainless steel or elements commonly found in stainless steel.
* Self-reported fear of blood.
* Self-reported circulatory conditions causing difficulty in drawing capillary blood.
* Known history of bleeding diathesis or any coagulation disorder.
* History of skin disorders, abnormal skin integrity or atypical skin health within the areas to be tested in the upper arm.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06761703
Study Brief:
Protocol Section:
NCT06761703